Teprotumumab for the Treatment of Active Thyroid Eye Disease
Teprotumumab for the Treatment of Active Thyroid Eye Disease
About this item
Full title
Author / Creator
Douglas, Raymond S , Kahaly, George J , Patel, Amy , Sile, Saba , Thompson, Elizabeth H.Z , Perdok, Renee , Fleming, James C , Fowler, Brian T , Marcocci, Claudio , Marinò, Michele , Antonelli, Alessandro , Dailey, Roger , Harris, Gerald J , Eckstein, Anja , Schiffman, Jade , Tang, Rosa , Nelson, Christine , Salvi, Mario , Wester, Sara , Sherman, Jeffrey W , Vescio, Thomas , Holt, Robert J and Smith, Terry J
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In a good example of translational research, investigators who had initially demonstrated a role for insulin-like growth factor I in the pathogenesis of thyroid eye disease showed that an antibody to the receptor (teprotumumab) produced a meaningful improvement in 83% of patients.
Alternative Titles
Full title
Teprotumumab for the Treatment of Active Thyroid Eye Disease
Authors, Artists and Contributors
Author / Creator
Kahaly, George J
Patel, Amy
Sile, Saba
Thompson, Elizabeth H.Z
Perdok, Renee
Fleming, James C
Fowler, Brian T
Marcocci, Claudio
Marinò, Michele
Antonelli, Alessandro
Dailey, Roger
Harris, Gerald J
Eckstein, Anja
Schiffman, Jade
Tang, Rosa
Nelson, Christine
Salvi, Mario
Wester, Sara
Sherman, Jeffrey W
Vescio, Thomas
Holt, Robert J
Smith, Terry J
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2344376562
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2344376562
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1910434
